Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu Content provided by Susan Anasagasti SAN ANTONIO, March 31, 2026 — The San Antonio Breast Cancer Symposium® drew more than 11,000 attendees to downtown San Antonio and generated nearly $40 million in economic impact, according to a new report from Visit San Antonio. Held each December at the Henry B. […]
Share This Story
UT Health San Antonio Multispecialty and Research Hospital has enrolled and treated its first clinical trial participant in a novel cancer study, marking a pivotal moment for science and patient-centered cancer care in San Antonio and South Texas.
Share This Story
National experts in cancer drug development gathered at a symposium hosted by the UT Health San Antonio Mays Cancer Center’s Experimental and Drug Therapeutics Program to discuss new strategies and opportunities in cancer research and tackle pressing challenges in patient care.
Share This Story
A large, retrospective study conducted by scientists at the University of Texas at San Antonio (UT San Antonio) suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists — medications that are widely prescribed for metabolic disease — have a significantly lower risk of developing colorectal cancer compared with those taking aspirin. “This is astounding to […]
Share This Story
This story was first published in the February 2026 issue of the Bexar County Medical Society’s San Antonio Medicine magazine. New face of head and neck cancer A healthy 40-year-old man visits his primary care physician for a mass on his neck. He doesn’t smoke, has no risk factors for head and neck cancer, […]
Share This Story
U.S. News & World Report: Ozempic, Wegovy Might Lower Colon Cancer Risk
Share This Story
MadePage Today: GLP-1 Use Linked to Lower Colon Cancer Risk vs Aspirin
Share This Story
Less-invasive RFA method seen as a complementary treatment UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and less-invasive treatment called radiofrequency ablation on a comorbid patient with a pancreatic cancer tumor that couldn’t be removed by surgery. The method, RFA for short, delivers controlled heat in […]
Share This Story
Research scientists and clinicians at UT Health San Antonio are working to halt one of the most persistent bacterial infections that silently affects millions of people worldwide. Helicobacter pylori (H. pylori) is a spiral-shaped bacterium capable of burrowing into the stomach lining and is the only bacterium known to directly cause cancer. Through leading […]
Share This Story
UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), received nearly $3 million in new academic and prevention awards as part of the latest, almost $154 million funding round announced on November 19 by the Cancer Prevention Research Institute of Texas (CPRIT). This brings CPRIT’s […]
Share This Story